Eledon Pharmaceuticals (NASDAQ:ELDN) Stock Rating Upgraded by HC Wainwright
Eledon Pharmaceuticals (NASDAQ:ELDN – Get Free Report) was upgraded by HC Wainwright to a “buy” rating in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm presently has a $9.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 223.74% from the stock’s current […]
Eledon Pharmaceuticals (NASDAQ:ELDN – Get Free Report) was upgraded by HC Wainwright to a “buy” rating in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm presently has a $9.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 223.74% from the stock’s current […]
